As per NPPA Order S.O. 5690(E) dated 17 October 2026, the trade margin on 137 non-scheduled anti-cancer medicines is capped at 30%. Hetero’s revised MRPs take effect on 9 November 2026.
Patients and partners with questions about the revised prices are welcome to speak to their doctor, pharmacist or hospital.
Source: NPPA Order S.O. 5690(E), The Gazette of India, 17 October 2026.
Hetero Healthcare's Volga Division provides focused therapeutic solutions for patients managing Urology and Nephrology conditions, with a particular emphasis on CKD-related anaemia. Since its launch, the division primarily concentrates on treating anaemia caused by chronic kidney disease and emphasises Hetero's ongoing commitment to advancing speciality healthcare across the nation. Browse our product range for effective, dependable treatment options.
View by-